Ahmedabad: Zydus Lifesciences Limited has announced that it has received in principle acceptability from World Health ...

"Google's DeepMind is explained ...

The Nifty Pharma index closed on a negative note on Wednesday. Shares of Granules India Ltd.(up 1.8 per cent), Zydus ...

Zydus Lifesciences advanced 1.71% to Rs 1,005.05 after the company received in principle acceptability from World Health Organisation (WHO) for its ZyVac TCV vaccine.

Zydus Lifesciences' ZyVac TCV receives WHO prequalification, eligible for U.N. procurement, combating typhoid fever in ...

Zydus Lifesciences' shares rose 2.81% after receiving WHO approval for its indigenously developed typhoid vaccine, ZyVac TCV, ...

Zydus Lifesciences' ZyVac TCV typhoid vaccine receives WHO prequalification, opening doors for UN procurement programs in ...

Indian multinational pharmaceutical company Zydus Lifesciences Ltd on Wednesday announced that its Typhoid Vi conjugate ...

Following are the top stories at 1 pm: NATION * CAL11 OD-CYCLONE-DANA-LANDFALL Cyclone 'Dana' likely to make landfall between Bhitarkanika park & Dhamra po ...

As per GAVI (2022) it is estimated that Typhoid accounts for an estimated 11 to 21 million cases of febrile illness and ...

ZyVac TCV is designed for active immunization against Salmonella typhi infection in individuals aged 6 months to 65 years.